Standpoint Research Downgrades Teva Pharma (TEVA) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Teva Pharma (TEVA) / Mylan (MYL) Combo Unlikely, Says Wells Fargo
October 3, 2014 1:24 PM EDTWells Fargo analyst Michael Faerm commented on speculation Teva Pharma (NYSE: TEVA) is interested in acquiring Mylan (NASDAQ: MYL). In his view, a potential deal has positives and negatives, and while it may be financially attractive he thinks it... More
